NetworkNewsBreaks – Aurora Cannabis, Inc. (TSX: ACB) (OTCQX: ACBFF) and CanniMed Therapeutics Inc. (TSX: CMED) Name Interim CEO of CanniMed

April 3, 2018 14:19:46

Aurora Cannabis, Inc. (TSX: ACB) (OTCQX: ACBFF), together with CanniMed Therapeutics Inc. (TSX: CMED), recently announced that Brent Zettl has resigned from his position as CEO of CanniMed. Andrċ Jérôme was appointed as interim CEO and Zettl will remain available to CanniMed and Aurora in an advisory capacity to assist during the integration period. This update comes as Aurora nears the completion of the acquisition of all the outstanding shares of CanniMed. “The integration of Aurora and CanniMed is well underway, and we anticipate updating the market frequently on developments as CanniMed is aligned with the Aurora Standard and expands its footprint in the domestic and international medical cannabis sectors,” Aurora CEO Terry Booth stated in the news release.

To view the full press release, visit

About CanniMed Therapeutics

CanniMed is a Canadian-based, international plant biopharmaceutical company and operating in the Canadian medical cannabis industry with 17 years of experience engaged in pharmaceutical cannabis cultivation, GMP-compliant production process and research and development platforms. CanniMed, through its subsidiaries, was licensed under the Marihuana for Medical Purposes Regulations, the predecessor to the current Access to Cannabis for Medical Purposes Regulations. It was the supplier to Health Canada under the former medical marijuana system for 13 years and has been producing safe and consistent medical marijuana for thousands of Canadian patients, with no incident of product diversion or recalls. For more information, visit the company’s website at

About Aurora

Aurora’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”). The company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, known as “Aurora Mountain”, and a second 40,000 square foot high-technology production facility known as “Aurora Vie” in Pointe-Claire, Quebec on Montreal’s West Island. In January 2018, Aurora’s 800,000 square foot flagship cultivation facility, Aurora Sky, located at the Edmonton International Airport, was licensed. Once at full capacity, Aurora Sky is expected to produce over 100,000 kg per annum of cannabis. Aurora is completing a fourth facility in Lachute, Quebec utilizing its wholly owned subsidiary Aurora Larssen Projects Inc. Aurora also owns and holds stake in numerous other businesses operating in the cannabis industry. For more information, visit the company’s website

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office